Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hemispherx BioPharma Inc. (HEB)’

Insider Trading Eyeglasses

Hedge Fund and Insider Trading News: Bill Ackman, Citadel LLC, Hemispherx Biopharma Inc (HEB), Gold Resource Corporation (GORO), Immunomedics Inc (IMMU), and More

Hedge Fund Citadel Executes Cleared Cash and Repo Trades Through DTCC (Global Custodian) Hedge fund giant Citadel has executed and cleared both cash Treasury......(read more)
Insider Trading, NYSE, Markets, Stock Trader On The Phone

Hedge Fund and Insider Trading News: Kyle Bass, Mike Novogratz, Aurelius Capital, Hemispherx Biopharma Inc (HEB), Lowe’s Companies, Inc. (LOW), and More

Hedge Fund Manager Kyle Bass Says the US has More Leverage Over China than Ever Before (CNBC) Hedge fund manager Kyle Bass believes the United States......(read more)
Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Elliott Management, Hemispherx BioPharma, Inc (HEB), International Flavors & Fragrances Inc (IFF), Yext Inc (YEXT), and More

Hedge Fund Elliott Again Raises Stake in Japan’s Alpine (Reuters) TOKYO (Reuters) – U.S. hedge fund Elliott Management has raised its stake......(read more)
Insider Trading Back

Hedge Fund and Insider Trading News: Visium Asset Management, Soros Fund Management, Citadel, Casa Systems Inc (CASA), Andeavor (ANDV), and More

SEC Charges Hedge Fund with Insider Trading, Inflating Fund Returns (MarketWatch) The Securities and Exchange Commission settled charges on Tuesday with......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks

By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

Hemispherx BioPharma, Inc (HEB) Spikes On Extension Of Rintatolimod European EAP To Pancreatic Cancer

Shares of Hemispherx BioPharma, Inc (NYSEMKT:HEB) gained more than 12.75% in the last three days of the week, after the company announced its rintatolimod......(read more)
Ligand, LGND, chemistry, test, isolated, experiment, nobody, microscopy, pharmaceutical, white, medical, pharmacology, study, laboratory, biotechnology, discovery, analysis,

Two Nano-Cap Pharma Stocks To Watch Right Now

Pharmaceutical stocks have had a tough year, with landmark ETFs like the PowerShares Dynamic Pharmaceuticals(ETF) (NYSEARCA:PJP) down about 18.7% since......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Nano-Cap Biotech Focus: Hemispherx BioPharma (HEB)’s Turnaround

Hemispherx BioPharma, Inc (NYSEMKT:HEB) is a nano-cap biopharmaceutical company focused on the treatment of seriously debilitating disorders. Its flagship......(read more)
insider trading insider buys

5 Noteworthy Insider Transactions Filed on Friday Amid Slowing Insider Trading Activity

U.S. equities rallied on Friday as the Labor Department revealed that U.S employers added 287,000 jobs in June, a big turnaround from the weak reports......(read more)
nike, store, symbol, logo, clothing, popular, mall, nobody, retail, outlet, corporate, clothes, day, architectural, consumerism, commercial, beijing, outside, chain, fashion,

Lands’ End Inc. (LE), Nike Inc. (NKE) and One Low-Priced Biopharmaceutical Company Register Insider Buying

Last week’s dollar volume of insider buying decreased by half relative to the volume registered in the prior week, whereas the volume of insider selling......(read more)